Log in to save to my catalogue

Effect of MP-AzeFlu compared to monotherapy on COX-2, PGE 2 , and EP2 gene expression in upper airwa...

Effect of MP-AzeFlu compared to monotherapy on COX-2, PGE 2 , and EP2 gene expression in upper airwa...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_1002_iid3_709

Effect of MP-AzeFlu compared to monotherapy on COX-2, PGE 2 , and EP2 gene expression in upper airway mucosa

About this item

Full title

Effect of MP-AzeFlu compared to monotherapy on COX-2, PGE 2 , and EP2 gene expression in upper airway mucosa

Publisher

England

Journal title

Immunity, Inflammation and Disease, 2023-01, Vol.11 (1), p.e709

Language

English

Formats

Publication information

Publisher

England

More information

Scope and Contents

Contents

MP-AzeFlu (intranasal fluticasone and azelastine) has been widely studied and has demonstrated efficacy in Allergic rhinitis with a superior effect compared to these drugs administered individually; however, the mechanism by which MP-AzeFlu produces this improved clinical effect has not yet been fully explained. In this study, we investigated the e...

Alternative Titles

Full title

Effect of MP-AzeFlu compared to monotherapy on COX-2, PGE 2 , and EP2 gene expression in upper airway mucosa

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_crossref_primary_10_1002_iid3_709

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_1002_iid3_709

Other Identifiers

ISSN

2050-4527

E-ISSN

2050-4527

DOI

10.1002/iid3.709

How to access this item